Margaret A. Hamburg, M.D.
Former Commissioner of the U.S. Food and Drug Administration
Margaret A. Hamburg, MD, Joins NTI as Interim Vice President for NTI | bio
NTI board member Margaret A. Hamburg, MD, is joining NTI’s leadership to serve as interim vice president of the NTI | bio program in February. Hamburg, an internationally recognized leader in public health and medicine, replaces Beth Cameron, PhD, who has moved to the White House to rebuild the National Security Council’s Office of Global Health Security and Biodefense and advance the Biden Administration’s agenda on global health security.
Hamburg’s relationship with NTI goes back to its launch in 2001, when she was named as the organization’s founding senior scientist and biological program vice president. She went on to become commissioner of the Food and Drug Administration and foreign secretary of the National Academy of Medicine.
Hamburg joined NTI’s Board of Directors in 2017.
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
More News
Shayna Korol Joins NTI as New Biosecurity Policy Fellow
NTI welcomes Shayna Korol as the Biosecurity Policy Fellow sponsored by the Open Philanthropy Technology Policy Fellowship.
NTI at the 10th NPT Review Conference
NTI will host three side events at the 10th NPT Review Conference.
NTI-WEF Technical Consortium for DNA Synthesis Screening Comments on Revised U.S. Government Guidance
The Technical Consortium for DNA Synthesis Screening, convened by NTI | bio and the World Economic Forum (WEF), responded to the U.S. government’s request for comment on its Revised Screening Framework Guidance for Providers and Users of Synthetic Oligonucleotides.
